Myocardial infarction in a young female smoker taking oral contraception;Infarctus du myocarde chez une jeune femme fumeuse sous contraception orale

Archives des Maladies du Coeur et des Vaisseaux

Volumn 99, Issue 1, 2006, Pages 80-85

  Cabou, C ^a   Lacroix, I ^a   Roncalli, J ^b   Elbaz, M ^a   Caillaux, D ^b   Damase Michel, C ^a   Fauvel, J M ^b   Montastruc, J L ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b CHU RANGUEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DROSPIRENONE; ETHINYLESTRADIOL; FIBRINOLYTIC AGENT; LEVONORGESTREL; ANDROSTANE DERIVATIVE; ORAL CONTRACEPTIVE AGENT;

ADULT; ANAMNESIS; ANGIOPLASTY; ARTICLE; BLOOD CLOT LYSIS; CASE REPORT; ECTOPIC PREGNANCY; FEMALE; HEART INFARCTION; HUMAN; ORAL CONTRACEPTION; OUTCOME ASSESSMENT; RISK ASSESSMENT; RISK FACTOR; SMOKING; PREGNANCY;

ADULT; ANDROSTENES; CONTRACEPTIVES, ORAL; ETHINYL ESTRADIOL; FEMALE; HUMANS; MYOCARDIAL INFARCTION; PREGNANCY; PREGNANCY, ECTOPIC; SMOKING;

EID: 33645060771     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Poulter NR, Chang CL, Farley TMM, Kelaghan J, Meirik O, Marmot MG. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. Lancet. 1997;349:1202-9.
2. Jick H, Dinan B, Herman R, Rothman KJ. Myocardial infarction and other vascular diseases in younq women: role of estrogens and other factors. JAMA. 1978; 240:2548-52.
3. Stadel BV. Oral contraceptive and cardiovascular disease. N Engl J Med. 1981;305:612-8.
4. Thprogood M, Vessey MP. An epidemiologic survey of cardiovascular disease in women taking oral contraceptives. Am J Obstet Gynecol. 1990;163:274-81.
5. Bottiger LE, Boman G, Eklund G, Westerholm B. Oral contraceptives and thrombo-embolic disease: effects of lowering oestrogen content. Lancet. 1980;1:1097-101.
6. Khader YS, Rice J, John L, Abueita O. Oral contraceptives use and the risk of myocardial infarction: a meta-analysis. Contraception. 2003;68:11-7.
7. Farley TMM, Meiric O, Chang CL, Marmot MG, Poulter NR. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet. 1995;346:1582-8.
8. Bloemenkamp KW, Rosendaal FR, Buller HR, Helmerhorst FM, Colly LP, Vandenbroucke JP. Risk of venous thrombosis with use of current low-dose oral contraceptives is not explained by diagnosis suspicion and referral bias. Arch Intern Med. 1999;159:65-70.
9. Kemmeren JM, Algra A, Grobbee DE. Third generation oral contraceptives and risk of venous thrombosis: meta-analysis. BMJ. 2001;323:131-4.
10. Herings RM, Urquhart J, Leufkens HG. Venous thromboembolism among new users of different oral contraceptives. Lancet. 1999;354:127-8.
11. Tanis BC, van den Bosch MA, Kemmeren JM, et al. Oral contraceptives and the risk of myocardial infarction. N Engl Med. 2001;345:1787-93.
12. Van Den Bosch MA, Kemmeren JM, Tanis BC, et al. The RATIO study: oral contraceptives and the risk of peripheral arterial disease in young women. J Thromb Haemost. 2003;1:439-44.
13. Kemmeren JM, Tanis BC, van den Bosch MA, et al. Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke. Stroke. 2002;33:1202-8.
14. Lewis MA, Heinemann LA, Spitzer WO, et al. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results for the Transnational Study on Oral Contraceptives and the Health of Young Women. Contraception. 1997;56:129-40.
15. Lidegaard O, Edström B. Oral contraceptives and acute myocardial infarction: a case- control study. Eur J Contracept Reprod Health Care. 1996;1:74.
16. Dunn NR, Arscott A, Thorogood M. The relationship between use of oral contraceptives and myocardial infarction in young women with fatal outcome, compared to those who survive: results from the MICA case-control study. Contraception. 2001;63:65-9.
17. Spitzer WO, Faith JM, MacRae KD. Myocardial infarction and third generation: aggregation of recent studies. Hum Reprod 2002;17:2307-14.
18. Parsey KS, Pong A. An open-label, multicenter study to evaluate YasminTM, a low-dose combination oral contraceptive containing drosperinone a new progestogen. Contraception 2000;61:105-11.
19. Sheldon T. Dutch GPs warned against new contraceptive pill. BMJ. 2002; 324:869.
20. Kieler H, Persson I, Odlind V. Venous thromboembolism and combined oral contraceptives. Reported adverse reactions indicate at least similar risk with the most recent contraceptive pills. Lakartidningen. 2003;100:3050-1
21. Mann JI, Doll R, Thorogood M, Vessey MP Waters WE. Risk factors myocardial infarction in young women. Br J Prev Soc Med. 1976;30:94-100.
22. Houssel P, Gouezec H, Malledant Y et al. Oral contraception and surgery. Cah Anesthesiol. 1989;37:451-4.
23. No authors listed. Drugs in the perioperative period: 3-Hormonal contraceptives and hormone replacement therapy. Drug Ther Bull. 1999;37:78-80.
24. De Lignieres B. Metabolic and vascular risks with oral contraceptives. Rev Prat. 1995;45:2423-9.
25. Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet. 1995;346:1589-93.
26. Fruzzetti FMD. Hemostatic effects of smoking and oral contraceptive use. Am J Obstet Gynecol 1999;180:369-74.
27. Lowe GD. Venous and arterial thrombosis: epidemiology and risk factors at various ages. Maturitas. 2004;47: 259-63.
28. Vandenbroucke JP, Koster T, Briet E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor Leiden mutation. Lancet. 1994;344:1453-7.
29. Simioni P, Sanson BJ, Prandoni P, et al. Incidence of venous thromboembolism in families with inherited thrombophilia. Thromb Haemost. 1999;81:198-202.
30. Martinelli I, Mannucci PM, De Stefano V, et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood. 1998;92:2353-8.
31. Tanis BC, Bloemenkamp DG, van den Bosch MA, et al. Prothrombotic coagulation defects and cardiovascular risk factors in young women with acute myocardial infarction. Br J Haematol. 2003;122:471-8.
32. Bonnar J. Changes in coagulation and fibrinolysis with low dose oral contraceptives. Adv Contracept. 1991;7:285-91.
33. Rosing J, Tans G, Nicolaes GA, et al. Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives. Br J Haematol. 1997;97:233-8.
34. Godsland IF, Crook D, Simpson R, et al. The effects of different formulations of oral contraceptive agents on lipids and carbohydrate metabolism. N Engl J Med. 1990;323:1375-81.
35. Cook NR, Scherr PA, Evans DA, et al. Regression analysis of changes in blood pressure with oral contraceptive use. Am J Epidemiol. 1985;121:530-40.
36. Beaufils M. Hypertension de la femme (contraception et ménopause). Arch Mal Cœur. 2000;93:1404-10.
37. Fotherby K. Pharmacokinetics of ethynyloestraaiol in humans. Methods Find Exp Clin Pharmacol. 1982;4:133-41.
38. Beaumont V, Lemort N, Beaumont JL. Oral contraceptif circulating immune complexes, anti-ethinyl estradiol antibodies and thrombosis. Am J Reprod Immunol. 1982;2:8-13.
39. Beaumont V, Lemort N, Beaumont JL. Oral contraceptives, sex steroid induced antibodies and vascular thrombosis results from 1318 cases. Eur Heart J. 1991;12:1219-24.
40. Dear HD, Jones WB. Myocardial infarction associated with the use of oral contraceptives. Ann Intern Med. 1971;74:236-9.
41. Engel HJ, Engel E, Lichtlen PR. Coronary atherosclerosis and myocardial infarction in young women. Role of oral contraceptives. Eur Heart J. 1983;4:1-6.
42. Irey NS, Manion WC, Taylor HB. Vascular lesions in women taking oral contraceptives. Arch Path. 1970;89:1-8.
43. Mann JI, Inman VH. Oral contraceptives and death from myocardial infarction. BMJ. 1975;2:245-8.
44. Begaud B, Evreux JC, Jouglard J, et al. Unexpected or toxic drug reaction assessment (imputation). Actualization of the method used in France. Therapie. 1985;40:115-8.